Goodbye Keanu my multiple myeloma story
I read about the famous American
basketball player Kareem Abdul Jabbar. He was diagnosed in 2008 with chronic
myeloid leukemia. He had sought medical advice after getting hot flushes every
night. He has been in remission ever since. I have been having hot flushes for
years. So when I was waving a fan over my face six months before I was
diagnosed I didn’t think it was a new symptom of anything. Now I know. In March 2012 I read the story of rugby legend Jock Hobbs. In 2010 his leukemia was in
a chronic form (slow progression of disease), by 2011 it was acute and he
succumbed. I couldn’t understand why he wasn’t treated more aggressively during
his “chronic” phase until I watched a You Tube
clip by a haematologist who explained that the drugs were not effective during
the chronic stage. But for those of us out here in the field, in the family of
cancer patients, it all seemed too little too late.
There were
days when hearing about people like Jock made me tense and nervous. I grew
tired of seeing the words: “a rare and aggressive disorder with poor prognosis”
as the first line of every treatise on PCL so I went searching for a better
outcome. I started to put in the words “surviving PCL” and “Can I survive PCL?”
into the search engine. I was confident I was getting the right treatment.
Everyone across the western world was on the same regime, chemo drugs followed
by either autologous or allogeneic transplant or both. But the outlook was
always grim.
I
was overwhelmingly depressed until I got on the site “Be the Match”. It was a
national bone marrow donor registry in America. My sister told me about them. As soon as she found
out about my disease she got in touch with them to find out about tissue typing.
She joined their registry to be a potential worldwide donor. The first thing
that hit my eye on their website was the chart of mortality rates. It showed
like 48% of people alive after six years. I slammed my fist on the table as if
I had accomplished this goal already. Perhaps I could make it through this?
Another site proclaimed 20 % of people had survived 10 years after treatment
with chemo drugs and a transplant. It didn’t say what diseases those people had
before their transplants. But why couldn’t I be one of the 20%?
I found another case study that cheered me up so much
I bounced to the other side of the room. It was about a 54-year-old woman who
achieved long-term complete remission from plasma cell leukemia after being
treated with chemotherapy and autologous stem cell transplantation. Fifty-six
months after the transplantation she remained in complete remission. She was
written up in a study by the department of medical oncology, Yamanashi
Prefectural Central Hospital, Japan. The report said:
“Taken together, although
primary plasma cell leukemia is a rare hematologic malignancy with poor
prognosis, (yes we know, we know) the intensive chemotherapy followed by tandem
autologous peripheral blood stem cell transplantation may well improve the clinical
outcome.”
That 54-year-old woman
became my idol.
It was impossible to know
what would happen. I knew that responding well to the chemo drugs initially
meant that I had a good chance of responding to them again when the leukaemia
returned. I was really well and that was a positive thing for going into the
stem cell transplant. The biggest things against me were my chromosomal
abnormalities. Generally they meant I would not do well for long. But I found a
window open in the research on both. So maybe I fit into the statistics or maybe I would be the exception. I
could be like the 54-year-old woman or 54 year-old African man, couldn’t I?
Because I responded so well
to the velcade, Alex asked the doctor if I could buy it after my
government-subsidised nine cycles were over. (It cost $2,000 a shot). The
doctor said yes, but there were other drugs they would be using as maintenance
therapy including thalidomide. He also said new drugs were being developed all
the time, like a liquid velcade .
So of course I did a little
more googling. Dr Comfort was right. There are lots of drugs under discussion
in the fight against multiple myeloma including pomalidomide, carfilzomib,
zolinza, panobinostat, obatoclax, daratumumab, SNS01-T and more. They are
nearly unpronounceable but very exciting. There are so many new medicines for
me to research, vocabulary to learn and trials to watch. I would keep my hands
hovering over the keyboard in anticipation. More than that, it gave me a window
of light from the cellar of my rare and aggressive disorder. With my poor
prognosis and the expectation that I had only two years left to live, the idea
that there might be a new drug that worked, or a chance that I could be one of
those people who get reports written about them for doing so well, gave me
something to cling on to.